HCPCS code J9022 — Inj, atezolizumab,10 mg.
Status: Active.
Effective Jan 1, 2018.
Source: CMS HCPCS Level II.
J9022
ActiveInj, atezolizumab,10 mg
Injection, atezolizumab, 10 mg
Category:
Drugs
Section:
J-codes: Drugs Administered Other Than Oral Method
Effective:
Jan 1, 2018
Code type:
alphanumeric
OPPS Status:
K
— Non-pass-through drugs and biologicals
OPPS APC:
9483
Drug class:
Anti-PD-L1 Checkpoint Inhibitors
MUE — Medically Unlikely Edits
Maximum units of J9022 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.
| Service Type | Max Units / Day |
|---|---|
| DME Supplier | 0 |
| Outpatient Hospital | 168 |
| Practitioner Services | 168 |
Source: CMS Medicare NCCI Medically Unlikely Edits
NDC Crosswalk
National Drug Codes (NDCs) mapped to this HCPCS code.
| NDC | Drug Name |
|---|---|
| 50242-0917-01 | Tecentriq |
| 50242-0918-01 | Tecentriq |